#BreakingNews for #investors and #media: We are proud to announce the U.S. FDA has approved our treatment for children and adults living with phenylketonuria (#PKU). Read the press release for more: https://t.co/l8dVB9zNyw
IPAD would like to congratulate @BerryS730, MD, professor, Division of Genetics and Metabolism, Department of Pediatrics, University of Minnesota, for receiving the Clinician Champion Award by the Association of Public Health Laboratories (APHL) at its 2022 Symposium!
Following a remarkable year of progress that included proof-of-concept in #PKU, today we look ahead to significant clinical milestones in 2022. See our press release for details https://t.co/Ehcz95XBc2
NORDβs PKU assistance program has been suspended until they secure funding for 2022. Share what NORD assistance means to you. https://t.co/PsqcKUZYcp Or send your letter directly to [email protected]. Comments due by SUN 1/9 @ 9:00 pm CT. More updates as available.
Congratulations to the 2021 RareVoice Award recipients! #rarevoice2021
In case you missed it, please enjoy #RareVoice2021 show here: https://t.co/ArKZHxRta1
To view full list of awardees visit: https://t.co/kHNeuIeYaX